Human CD1c+ dendritic cells drive the differentiation of CD103+ CD8+ mucosal effector T cells via the cytokine TGF-β.
Animals, Antigens, CD, Antigens, CD1, Antigens, Viral, CD8-Positive T-Lymphocytes, Cell Differentiation, Cells, Cultured, Cytotoxicity, Immunologic, Dendritic Cells, Glycoproteins, Humans, Immunity, Mucosal, Immunologic Memory, Influenza Vaccines, Integrin alpha Chains, Lung, Lymphocyte Activation, Mice, Mice, SCID, Microarray Analysis, T-Lymphocyte Subsets, Transforming Growth Factor beta
Immunity 2013 Apr 18; 38(4):818-30.
In comparison to murine dendritic cells (DCs), less is known about the function of human DCs in tissues. Here, we analyzed, by using lung tissues from humans and humanized mice, the role of human CD1c(+) and CD141(+) DCs in determining the type of CD8(+) T cell immunity generated to live-attenuated influenza virus (LAIV) vaccine. We found that both lung DC subsets acquired influenza antigens in vivo and expanded specific cytotoxic CD8(+) T cells in vitro. However, lung-tissue-resident CD1c(+) DCs, but not CD141(+) DCs, were able to drive CD103 expression on CD8(+) T cells and promoted CD8(+) T cell accumulation in lung epithelia in vitro and in vivo. CD1c(+) DCs induction of CD103 expression was dependent on membrane-bound cytokine TGF-β1. Thus, CD1c(+) and CD141(+) DCs generate CD8(+) T cells with different properties, and CD1c(+) DCs specialize in the regulation of mucosal CD8(+) T cells. Immunity 2013 Apr 18; 38(4):818-30.
Human CD1c+ dendritic cells drive the differentiation of CD103+ CD8+ mucosal effector T cells via the cytokine TGF-β. Immunity 2013 Apr 18; 38(4):818-30.